IP Library › Assignment 048407/0911
Patent Assignment
Reel/Frame 048407/0911

Assignment of Assignor's Interest

Recorded: 2019-02-21 Pages: 28
Assignor
THE MEDICINES COMPANY
Executed: 2018-01-05
Assignee
MELINTA THERAPEUTICS, INC.
300 GEORGE STREET, SUITE 301, NEW HAVEN, CONNECTICUT, 06511
Covered Properties (14)
Use of Oritavancin for Prevention and Treatment of Anthrax
Patent: 9,089,507 →
Application: 12/442,751 →
Publication: US 2010/0041585
Method of Inhibiting Clostridium Difficile by Administration of Oritavancin
Patent: 8,518,873 →
Application: 12/676,420 →
Publication: US 2010/0311646
Methods of Treating Bacterial Infections Using Oritavancin
Patent: 9,682,061 →
Application: 12/740,571 →
Publication: US 2012/0035097
Methods of Treatment Using Single Doses of Oritavancin
Patent: 8,420,592 →
Application: 13/060,811 →
Publication: US 2011/0201546
Glycopeptide and Lipoglycopeptide Antibiotics with Improved Solubility
Patent: 8,901,072 →
Application: 13/389,993 →
Publication: US 2012/0149632
Disk Diffusion Assay for Oritavancin
Patent: 8,815,535 →
Application: 13/559,060 →
Publication: US 2013/0029371
Methods of Treatment Using Single Doses of Oritavancin
Application: 13/763,799 →
Publication: US 2013/0172237
Method of Inhibiting Clostridium Difficile by Administration of Oritavancin
Patent: 8,629,100 →
Application: 13/950,202 →
Publication: US 2013/0310308
Method of Inhibiting Clostridium Difficile by Administration of Oritavancin
Patent: 9,220,749 →
Application: 14/101,645 →
Publication: US 2014/0100157
Treatment and Prevention of Bacterial Skin Infections Using Oritavancin
Application: 14/786,106 →
Publication: US 2016/0101148
High Purity Oritavancin and Method of Producing Same
Patent: 9,649,352 →
Application: 14/801,303 →
Publication: US 2016/0015772
Methods for Treating Bacterial Infections Using Oritavancin and Polymyxins
Patent: 9,775,878 →
Application: 14/914,773 →
Publication: US 2016/0206687
Methods for Treating Bacteremia and Osteomyelitis Using Oritavancin
Application: 14/914,792 →
Publication: US 2016/0206688
High Purity Oritavancin and Method of Producing Same
Application: 15/439,206 →
Publication: US 2017/0157206
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 22, 2012
From: BELLEY, ADAM
To: THE MEDICINES COMPANY
Reel/Frame 028828/0227 →
Assignment of Assignor's Interest Jul 31, 2013
From: TARGANTA THERAPEUTICS CORP.
To: THE MEDICINES COMPANY
Reel/Frame 030916/0580 →
Assignment of Assignor's Interest Oct 17, 2013
From: TARGANTA THERAPEUTICS CORP.
To: THE MEDICINES COMPANY
Reel/Frame 031428/0744 →
Assignment of Assignor's Interest Feb 6, 2017
From: CHEMBURKAR, SANJAY R.; KNABLE, CARL M.; PETZEL, JAMES; PRUYNE, JULIE J.
To: ABBVIE INC.
Reel/Frame 041183/0774 →
Assignment of Assignor's Interest Feb 7, 2017
From: RAFAI FAR, ADEL; KRISHNA, GOPAL; DING, MIN
To: THE MEDICINES COMPANY
Reel/Frame 041192/0811 →
Assignment of Assignor's Interest Apr 10, 2017
From: CHEMBURKAR, SANJAY R.; KNABLE, CARL M.; PETZEL, JAMES; PRUYNE, JULIE J.
To: ABBVIE INC.
Reel/Frame 041937/0828 →
Assignment of Assignor's Interest Apr 10, 2017
From: RAFAI FAR, ADEL; KRISHNA, GOPAL; DING, MIN
To: THE MEDICINES COMPANY
Reel/Frame 041937/0775 →
Assignment of Assignor's Interest Jul 31, 2017
From: MOECK, GREGORY; ARHIN, FRANCIS
To: THE MEDICINES COMPANY
Reel/Frame 043147/0703 →
Assignment of Assignor's Interest Aug 15, 2017
From: MOECK, GREGORY; ARHIN, FRANCIS
To: THE MEDICINES COMPANY
Reel/Frame 043296/0789 →
Security Interest Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Assignment of Assignor's Interest Feb 21, 2019
From: LEHOUX, DARIO; PARR, THOMAS R.; MOECK, GREGORY; ETIENNE, PIERRE
To: TARGANTA THERAPEUTICS CORP.
Reel/Frame 048400/0572 →
Assignment of Assignor's Interest Feb 21, 2019
From: WILCOX, MARK HARVEY; BAINES, SIMON
To: UNIVERSITY OF LEEDS
Reel/Frame 048400/0254 →
Assignment of Assignor's Interest Feb 21, 2019
From: LEHOUX, DARIO; PARR, THOMAS REEVES, JR
To: TARGANTA THERAPEUTICS CORP.
Reel/Frame 048400/0331 →
Assignment of Assignor's Interest Feb 21, 2019
From: UNIVERSITY OF LEEDS
To: THE MEDICINES COMPANY
Reel/Frame 048400/0438 →
Assignment of Assignor's Interest Feb 21, 2019
From: TARGANTA THERAPEUTICS CORP.
To: THE MEDICINES COMPANY
Reel/Frame 048400/0485 →
Assignment of Assignor's Interest Feb 21, 2019
From: TARGANTA THERAPEUTICS CORP.
To: THE MEDICINES COMPANY
Reel/Frame 048400/0612 →
Assignment of Assignor's Interest Nov 19, 2019
From: MOECK, GREG; MATKOVITS, THERESA; EAGLE, GINA; PATEL, KETNA
To: THE MEDICINES COMPANY
Reel/Frame 051057/0929 →
Intellectual Property Security Agreement Dec 22, 2020
From: MELINTA THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 054836/0765 →
Amended and Restated Intellectual Property Security Agreement Aug 25, 2022
From: TARGANTA THERAPEUTICS CORPORATION
To: SILICON VALLEY BANK
Reel/Frame 061314/0659 →
Amended and Restated Intellectual Property Security Agreement Aug 25, 2022
From: MELINTA THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 061314/0459 →
Assignment of Assignor's Interest May 5, 2023
From: ABBVIE INC.
To: MELINTA THERAPEUTICS LLC
Reel/Frame 063552/0654 →
Termination and Release of Intellectual Property Security Agreement (Patents) at Reel 054836 and Frame 0765 and Reel 061314 and 0459 Aug 29, 2025
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: MELINTA THERAPEUTICS, LLC
Reel/Frame 072772/0097 →
Termination and Release of Intellectual Property Security Agreement (Patents) at Reel 061314 and Frame 0659 Aug 29, 2025
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: TARGANTA THERAPEUTICS CORPORATION
Reel/Frame 073724/0550 →
Change of Name Sep 23, 2025
From: MELINTA THERAPEUTICS, INC
To: MELINTA THERAPEUTICS, LLC
Reel/Frame 072952/0173 →